J. Kraft

Tissue levels of retinoids in human embryos/fetuses.

T. Shepard, M. Juchau, J. C. Kraft, 1993, Reproductive toxicology.

Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.

H. Nau, D. Kochhar, W. Scott, 1987, Toxicology and applied pharmacology.

9-cis-retinoic acid: a direct-acting dysmorphogen.

M. Juchau, J. C. Kraft, J. Kraft, 1993, Biochemical pharmacology.

Microinjections of cultured rat conceptuses: studies with 4-oxo-all-trans-retinoic acid, 4-oxo-13-cis-retinoic acid and all-trans-retinoyl-beta-glucuronide.

M. Juchau, R. Bechter, J. C. Kraft, 1992, Teratology.

Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.

H Nau, H. Nau, W. Wittfoht, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Automated Determination of 13-Cis-and All-Trans-Retinoic Acid, Their 4-Oxo-Metabolites and Retinol in Plasma, Amniotic Fluid and Embryo by Reversed-Phase High-Performance Liquid Chromatography with a Precolumn Switching Technique

H. Nau, W. Kuhnz, B. Löfberg, 1988 .

The retinoid X receptor ligand, 9-cis-retinoic acid, is a potential regulator of early Xenopus development.

D. Kimelman, M. Juchau, J. C. Kraft, 1994, Proceedings of the National Academy of Sciences of the United States of America.

v-erbA and citral reduce the teratogenic effects of all-trans retinoic acid and retinol, respectively, in Xenopus embryogenesis.

D. Kimelman, M. Privalsky, J. C. Kraft, 1993, Development.

Retinoid metabolism in the embryo

J. C. Kraft, J. Kraft, 2000 .